Treatment of differentiated thyroid cancers: Nodular form;Traitement des cancers thyroidiens differencies a forme nodulaire

Annales d'Endocrinologie

Volumn 58, Issue 3, 1997, Pages 211-215

  Tourniaire, J ^a   Bernard, M H ^a   Bertholon Gregoire, M ^a   Adeleine, P ^b   Berger Dutrieux, N ^b  

^a UNIVERSITÉ LYON 1   (France)

^b HÔTEL DIEU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

THYROXINE; RADIOACTIVE IODINE; THYROID HORMONE;

DRUG EFFICACY; HUMAN; HUMAN CELL; HUMAN TISSUE; LARYNGEAL NERVE; OSTEOPENIA; PAPILLARY CARCINOMA; PROGNOSIS; RADIOIODINATION; REVIEW; SCORING SYSTEM; THYROID CANCER; THYROIDECTOMY; THYROTOXICOSIS; ADENOCARCINOMA; ADULT; FEMALE; MALE; MIDDLE AGED; STATISTICS; THYROID TUMOR;

ADENOCARCINOMA, FOLLICULAR; ADULT; FEMALE; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; PROGNOSIS; THYROID HORMONES; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 0030959117     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. BIONDI B, FAZID S, CARELLA C, AMATO G, CITTADINI A, LUPOLI G, SACCA L, BELLASTELLA A, LOMBARDI G. Cardiac effects of long-term suppressive therapy with levothyroxine. J. Clin. Endocrinol. Metab : 1993 77 - 334-8.
2. BIONDI B, FAZIO S, CARELLA C, SABATINI D, AMATO G, CITTADINI A, BELLASTELLA A, LOMBARDI G, SACCA L. Control of adreneric overactivity by betablockade improves the quality of life in patients receiving long term suppressive therapy with levothyroxine. J. Clin. Endocrinol. Metab. 1994 78 - 1028-33.
3. BRENNAN MD, BERGSTRALH EJ, VAN HEERDEN JA, MC CONAHEY WM. Follicular thyroid cancer treated at the Mayo Clinic 1946 through 1970 : initial manifestations, pathologic findings, therapy, and autcome. Mayo. Clin. Proc : 1991 66 - 11-22.
4. BURMEISTER L, GOUMAZ M, MARIASH C, OPPENHEIMER J. Levothyroxine dose requirements for thyrotropin suppression in the treatement of differentiated thyroid cancer J. Clin. Endocrinol. Metab. 1992. 75 - 344-50.
5. BUSHNELL DL, BOLES MA, KAUFMAN GE, WADAS MA, BARNES WE. Complications, sequela and dosimetry of iodine 131 therapy for thyroid carcinoma. J. Nucl. Med. 1992. 33 - 2214-21.
6. CADY B, COHN K, ROSSI RL, SEDOWICK CE, MEISSNER WA, WEBER J, GELMAN RS. The effect of thyroid hormone administration upon survival in patients with differentiated thyroid carcinoma. Surgery 1983. 94 - 978-83.
7. CADY B, ROSSI R. An expanded view of risk group definition in differentiated thyroid carcinoma. Surgery., 1988. 104 - 947-53.
8. CUNNINGHAM MP, DUDA RB, RECANT W, CHMIEL JS, SYLVESTER JA, FREMGEN A Survival discriminants for differentiated thyroid cancer. Am. J. Surg. 1990. 160 - 344-7.
9. DE GROOT LJ, KAPLAN EL, MC CORMICK M, STRAUS FH. Natural history, treatment, and course of papillary thyroid carcinoma. J. Clin Endocrinol. Metab 1990 71 - 414-24
10. DE GROOT LJ, KAPLAN EL, MC CORMICK M, STRAUS FH. Morbidity and mortality in follicular thyroid cancer. J Clin. Endocrinol. Metab 1995. 80 - 2946-53.
11. DULGEROFF AJ, HERSHMAN JM. Medical therapy for differentiated thyroid carcinoma. Endocr. Rev. 1994. 15-500-15.
12. FABER J, GALLOE AM. Changes in bone mass during prolonged subclinical hyperthyroidism due to 1 thyroxine treatment : a meta-analysis. Eur. J. Endocrinol 1994 130 - 350.
13. FRANKLYN JA, BETTERIDGE J, DAYKIN J, HOLDER R, OATES GD, PARLE JV, LILLEY J, HEATH DA, SHEPPARD MC. Long-term thyroxine treatment and bone mineral density. Lancet., 1992. 340 - 9-13.
14. FLYNN MB, LYONS KJ, TARTER JW, RAGSDALE TL. Local complications after surgical resection for thyroid carcinoma. Am J. Surg. - 1994. 168 - 404-7.
15. GHARIB H. Current evaluation of thyroid nodules. TEM - 1994. 5 - 365-9.
16. GHARIB H. Fine-needle aspiration biopsy of thyroid nodules : advantages, limitations, and effect. Mayo Clinic. Proc. 1994. 69 - 44-9.
17. HARVEY RD, MATHESON NA, GRABOWSKI PS, RODGER AB Measurement of serum thyroglobulin is of value in detecting tumour recurrence following treatment of differentiated thyroid carcinoma by lobectomy. Br J. Surg - 1990. 77 - 324-6.
18. HAY ID, GRANT CS, TAYLOR WF, MC CONAHEY WM. Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma : a retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery., 1987. 102 - 1088-95.
19. HAY ID, BERGSTRALH EJ, GOELLNER JR, EBERSOLD JR, GRANT CS. Predecting outcome in papillary carcinoma : development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery. - 1993. 114 - 1050-58.
20. 3 W.B. SAUNDERS Co. Philadelphia 1992. pp. 406-413.
21. JAFFIOL C, DAURES JP, PUJOL P, NSAKALA N, GUERENOVA J, BALDET L, VANNEREAU D, BRINGER J. TSH suppression in the course of differentiated thyroid cancer. Thyroid. 5. suppl. 1.S 88. Abstract no 176. 1995.
22. KLEIN I, OJAMAA K. Thyroid hormone and the cardiovascular system from theory to practice. J. Clin. Endocrinol. Metab., 1994. 78 - 1026-7.
23. KUNG AWC, YEUNO SSC. Prevention fo bone loss induced by thyroxine suppressive therapy in post menopausal women : the effect of calcium and calcitonin. J. Clin. Endocrinol. Metab. - 1996. 81 - 1232-6
24. LEESE GP, JUNG RT, GUTHRIE C, WAUGH N, BROWNING MCK. Morbidity in patients on 1-thyroxine : a comparaison of those with a normal TSH to those with a suppressed TSH. Clin. Endocrinol (Oxf.) - 1992. 37 - 500-3.
25. LEPRAT F, AUSTYN C, COMMENGES-DUCLOS M, COMMENGES D, COCHET C, BASSE-CATALINAT B, DUCASSOU D, LATAPIE JL. Risque osseux de l'opothërapie freinatrice dans l'épithélioma différencié de la thyroïde. Ann. Endocrinol (Paris) 1992. 53 - 224-9.
26. MAZZAFERRI EL, JHIANG SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am. J. Med. 1994. 97 - 418-28.
27. MAZZAFERRI EL, YOUNG RL. Papillary thyroid carcinoma : a 10 year follow-up report of the impact of therapy in 576 patients. Am. J. Med. 1981. 70 - 511-8.
28. MC COHANEY WM, HAY ID, WOOLNER LB, VAN HEERDEN JA, TAYLOR WF. Papillary thyroid cancer treated at the Mayo Clinic 1946 through 1970 : initial manifestations, pathologic findings, therapy an outcome. Mayo. Clin. Proc 1986.61 - 978-86.
29. MESNARD X. TSH 3 generation ACS TSH 3 (Ciba Coming Diagnostics). Évaluation analytique et application clinique à l'exploration du fremage thyréotrope des cancers thyroidiens différenciés. Mémoire DES Biologie Médicale. Lyon. 1996.
30. MORTENSEN JD, WOOLNER LB, BENNETT WA. Gross and microscopic findings in clinically normal thyroid glands. J. Clin. Endocrinol. Metab. 1955. 15 - 1270-80.
31. NICOLOFF JT, SPENCER CA. Non thyrotropin dependent thyroid secretion. J. Clin. Endocrinol. Metab. 1992. 75 - 343.
32. PUGEAT M, CRAVE JC, TOURNIAIRE J, FOREST MG. Clinical utility of sex hormon binding globulin measurement. Horm. Res. 1996. 45 - 148-55.
33. ROSEN HN, MOSES AC, GUNDBERG C, KUNG VT, SEYEDIN SM, CHEN T, HOLICK M, GREENSPAN SL. Therapy with patenteral pamidronate prevents thyroid hormone-induced bone turnover in humans. J. Clin. Endocrinol. Metab. 1993. 77 - 664-69.
34. 131I and external radiation in the treatment of local and metastatic thyroid cancer. In FALK S A. (ed). Thyroid disease . Endocrinology, Surgery, Nuclear Medicine, and Radiotherapy. Raven Press Ltd. New York 1990. pp. 537-552.
35. SHAH J, LOREE TR, DHARKER D, STRONG EW. Lobectomy versus total thyroidectomy for differentiated carcinoma of the thyroid : a matched-pair analysis. Am. J. Surg. 1993. 166 - 331-5.
36. SIMPSON WJ, PANZARELLA T, CARRUTHERS JS, GOSPODAROWICZ MK, SUTCLIFFE SB. Papillary and follicular thyroid cancer : impact of treatment in 1578 patients. Int. J. Radiat. Oncol. Biol Phys 1988. 14 - 1063-75
37. TOURNIAIRE J, BERNARD-AUGER MH, ADELEINE P, MILAN JJ, FLEURY-GOYON MC, DUTRIEUX-BERGER N. Les elements du pronostic des cancers thyroïdiens différenciés. Ann. Endocrinol. (Paris). 1989. 50 - 219-24.
38. TOURNIAIRE J, BERNARD MH, AYZAC L, NICOLAS MH, BORNET H. Dosage de la thyroglobuline sérique après lobectomie thyroidienne totale unilatérale pour cancer thyroïdien différencié. Presse. Med. 1990. 19 - 1309-12.
39. TOURNIAIRE J, BERNARD MH, BIZZOLLON-ROBLIN MH, PEIX JL, BERGER N. Pronostic des micro-carcinomes papillaires du corps thyroïde (140 cas observés depuis 1973). XIV Congrès de la Société Française d'Endocrinologie. Angers 1996, C. 0.7 - Ann. Endocrinol (Paris). 1996. 57 - 280.
40. VAN HERUE AJ. The thyroid nodule. Ann. Intern. Med. - 1982. 96 - 221-32.